Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Sleeping Sickness

Sleeping Sickness

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Sleeping Sickness

4 trials tracked for Sleeping Sickness: 4 in phase 3 or 4 and 3 with published results. The most-cited published study has 115 citations.

4Trials tracked
4Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 3 4
  1. Phase 3 Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense Completed · 115 cited
  2. Phase 3 Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense Completed · 9 cited
  3. Phase 3 Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage Completed · 6 cited
  4. Phase 3 Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report describes rhodesiense sleeping sickness in U.S. traveler returning from Zimbabwe
Infectious Disease
Case report describes rhodesiense sleeping sickness in U.S. traveler returning from Zimbabwe A U.S. traveler returned from Zimbabwe with sleeping sickness. What happened?
A case report describes a single case of rhodesiense human African trypanosomiasis (sleeping sickness) in a U.S.
A U.S. traveler returned from Zimbabwe with sleeping sickness, a fatal illness caused by a parasite from tsetse flies that can affect the br…
CDC Apr 5, 2026